Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Revenue: 2010-2025

Historic Revenue for Celldex Therapeutics (CLDX) over the last 15 years, with Jun 2025 value amounting to $730,000.

  • Celldex Therapeutics' Revenue fell 70.78% to $730,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $5.8 million, marking a year-over-year decrease of 30.25%. This contributed to the annual value of $7.0 million for FY2024, which is 1.99% up from last year.
  • According to the latest figures from Q2 2025, Celldex Therapeutics' Revenue is $730,000, which was up 5.04% from $695,000 recorded in Q1 2025.
  • Celldex Therapeutics' Revenue's 5-year high stood at $4.1 million during Q4 2023, with a 5-year trough of $153,000 in Q3 2021.
  • Over the past 3 years, Celldex Therapeutics' median Revenue value was $1.1 million (recorded in 2023), while the average stood at $1.5 million.
  • Its Revenue has fluctuated over the past 5 years, first spiked by 1,374.58% in 2021, then crashed by 95.32% in 2022.
  • Over the past 5 years, Celldex Therapeutics' Revenue (Quarterly) stood at $334,000 in 2021, then soared by 382.93% to $1.6 million in 2022, then spiked by 156.11% to $4.1 million in 2023, then crashed by 71.56% to $1.2 million in 2024, then tumbled by 70.78% to $730,000 in 2025.
  • Its Revenue stands at $730,000 for Q2 2025, versus $695,000 for Q1 2025 and $1.2 million for Q4 2024.